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The objective was to assess the effect of topically administered diclofenac on peripheral nerve regener-
ation and functional recovery. Eighty male healthy white Wistar rats were divided into four experimental
groups (n ¼ 20), randomly: In transected group (TC), left sciatic nerve was transected and stumps were
ﬁxed in the adjacent muscle. In treatment group defect was bridged using an artery graft (AG/DICLO) ﬁlled
with 10 mL diclofenac (0.1 mg/kg). In artery graft group (AG), the graft was ﬁlled with phosphate-buffered
saline alone. In sham-operated group (SHAM), sciatic nerve was exposed and manipulated. Each group
was subdivided into four subgroups of ﬁve animals each and regenerated nerve ﬁbers were studied 4, 8,
12 and 16 weeks after surgery. Behavioral testing, sciatic nerve functional study, gastrocnemius muscle
mass and morphometric indices conﬁrmed faster recovery of regenerated axons in AG/DICLO than AG
group (p < 0.05). In immunohistochemistry, location of reactions to S-100 in AG/DICLO was clearly more
positive than that in AG group. When loaded in an artery graft, diclofenac improved functional recovery
and morphometric indices of sciatic nerve. Topical application of this readily available agent offers the
beneﬁt of cost savings as well as avoiding the complications associated with systemic administration.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Peripheral nerve contains both dendrites and axons which
conduct information to (afferent) or from (efferent) the CNS,
respectively. Although the smallest axons are unmyelinated, most
axons in a peripheral nerve are myelinated with the multiple
concentric layers of lipid-rich, biochemically modifying plasma
membrane produced by Schwann cells. Schwann cells and their
endoneurial extracellular matrix play pivotal roles in the selective
promotion of motor and sensory axon regeneration.1When an axon
is crushed or severed, changes occur on both sides of the lesion.2
Where a gap is present between the severed ends of the nerve,
proliferating Schwann cells emerge from the stumps (mainly the
distal stump) and form a series of nucleated cellular cords (the
bands of Bungner) which bridge the interval.3
The conduits act to guide axons sprouting from the regenerating
nerve end, provide a microenvironment for diffusion of neuro-
trophic and neurotrophic factors secreted by the injured nerve
stump, as well as help protect from inﬁltration of ﬁbrous tissue.4 An
artery graft presents large quantities of laminin and some collagen.: þ98 441 277 19 26.
hammadi).
ciates Ltd. Published by Elsevier LtThese substances are also found in Schwann-cell basal membrane
and are reported as axonal outgrowth factors.5e11
Laminin, one of the main basal membrane components, stim-
ulates neurite outgrowth, induces Schwann-cell mitosis, and plays
a fundamental role in peripheral nerve regeneration.12,13
As well as requiring nerve ﬁber contact, normal Schwann-cell
differentiation requires contact with a connective tissue matrix or
some associated material such as collagen.14
The inﬂammatory process and its mediators have been impli-
cated in the regulation of the axonal regenerative processes after
injury.15,16 Gastrointestinal effects, ranging from relatively mild
dyspepsia to potentially lethal gastrointestinal (GI) bleeding and
perforated ulcers of chronic administration of NSAIDs are well-
known adverse effects of these compounds.17
The present study was conducted to evaluate possible local ef-
fect of diclofenac on peripheral nerve regeneration in a rat sciatic
nerve transection model.
2. Materials and methods
2.1. Study design and animals
Eighty male Wistar rats weighing approximately 280 g were divided into four
experimental groups (n ¼ 20), randomly: sham-operation group as normal control
(SHAM), transected control (TC), artery graft (AG) and diclofenac treated group (AG/
DICLO). Twenty rats were used as artery graft donors. Each group was furtherd. All rights reserved.
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weeks after surgery. Two weeks before and during the experiments, the animals
were housed in individual plastic cages with an ambient temperature of (23  3) C,
stable air humidity and a natural day/night cycle. The rats had free access to standard
rodent laboratory food and tap water. All measurements were made by two blinded
observers unaware of the analyzed groups.
2.2. Surgical procedure
Animals were anesthetized by intraperitoneal administration of ketaminee
xylazine (ketamine 5%, 90 mg/kg and xylazine 2%, 5 mg/kg). The procedure was
carried out based on the guidelines of the Ethics Committee of the International
Association for the Study of Pain.18 The University Research Council approved all
experiments.
Following surgical preparation in the sham-operation group, the left sciatic
nerve was exposed through a gluteal muscle incision and after careful homeostasis
the muscle was sutured with resorbable 4/0 sutures, and the skin with 3/0 nylon. In
TC group, the left sciatic nerve was transected proximal to the tibio-peroneal
bifurcation where a 7 mm segment was excised, leaving a 10 mm gap due to
retraction of nerve ends. Proximal and distal stumps were ﬁxed in the adjacent
muscle with 10/0 nylon epineurial suture. No graft was interposed between the
stumps. In the AG group, a 7 mm nerve segment was resected to produce a 10 mm
nerve gap after retraction of the nerve transected ends. The gap was bridged using
an artery graft, entubulating 2 mm of the nerve stump at each end. The artery graft
was harvested from abdominal aorta of donor animals. The abdominal aorta artery
was exposed through a midline abdominal incision and cannulated. Then, a 15 mm
segment was harvested on the cannula. Donor animals were sacriﬁced after har-
vesting with overdose of anesthetic. Harvested grafts were washed in physiological
solution and left at room temperature for 40 min. A subtle retraction of 1 mm was
already expected. Allografts did not receive preliminary treatment to reduce their
antigenicity. Two 10/0 nylon sutures were used to anchor the graft to the epi-
neurium at each end. In diclofenac treated group (AG/DICLO) the graft was ﬁlled
with 10 ml diclofenac (0.1 mg/mL). The animals were anesthetized and euthanized
with transcardiac perfusion of a ﬁxative containing 2% paraformaldehyde and 1%
glutaraldehyde buffer (pH 7.4) 4, 8, 12 and 16 weeks after surgery.
2.3. Behavioral testing
Functional recovery of the nerve was assessed using the Basso, Beattie, and
Bresnahan (BBB) locomotor rating scale for rat hind limbmotor function.19 Although
BBB is widely used to assess functional recovery in spinal cord injured animals,Table 1
The 21-point Basso, Beattie, Bresnahan locomotor rating scale and operational deﬁnition
Score Deﬁnition
0 No observable hind limb (HL) movement
1 Slight movement of one or two joints, usually the hip and/or Knee
2 Extensive movement of one joint or extensive movement of one joint a
3 Extensive movement of two joints
4 Slight movement of all three joints of the HL
5 Slight movement of two joints and extensive movement of the third
6 Extensive movement of two joints and slight movement of the third
7 Extensive movement of all three joints of the HL
8 Sweeping with no weight support or plantar placement of the paw with
9 Planter placement of the paw with weight support in stance only (i.e., w
stepping and no plantar stepping
10 Occasional weight supported plantar steps, no forelimb (FL)-HL coordin
11 Frequent to consistent weight supported plantar steps and no FL-HL coo
12 Frequent to consistent weight supported plantar steps and occasional FL
13 Frequent to consistent weight supported plantar steps and frequent FL-
14 Consistent weight supported plantar steps, consistent FL-HL coordinatio
externally) when it makes initial contact with the surface as well as jus
FL-HL coordination, and occasional dorsal stepping
15 Consistent plantar stepping and consistent FL-HL coordination; and no t
predominant paw position is parallel to the body at initial contact
16 Consistent plantar stepping and consistent FL-HL coordination during g
predominant paw position is parallel at initial contact and rotated at lift
17 Consistent plantar stepping and consistent FL-HL coordination during g
predominant paw position is parallel at initial contact and lift off
18 Consistent plantar stepping and consistent FL-HL coordination during g
predominant paw position is parallel at initial contact and rotated at lift
19 Consistent plantar stepping and consistent FL-HL coordination during g
predominant paw position is parallel at initial contact and lift off; and t
20 Consistent plantar stepping and consistent coordinated gait; consistent
off; tail consistently up; and trunk instability
21 Consistent plantar stepping and consistent coordinated gait, consistent
consistent trunk stability, tail consistently uphowever, it has been demonstrated that it could be most useful in assessment of
never repair processes in peripheral nerve injuries.20 Scores of 0 and 21 were given
when there were no spontaneous movement and normal movement, respectively. A
score of 14 shows full weight support and complete limbs coordination (Table 1).
BBB recordings were performed by a trained observer who was blinded to the
experimental design. The testing was performed in a serene environment. The an-
imals were observed and assessed within a course of a 4-min exposure to an open
area of a mental circular enclosure. BBB scores were recorded once before surgery in
order to establish a baseline control and againweekly thereafter to assess functional
recovery during 16 weeks.
2.4. Functional assessment of nerve regeneration
Walking track analysis was performed 4, 8, 12, 16 weeks after surgery based on
the method of others.21 The lengths of the third toe to its heel (PL), the ﬁrst to the
ﬁfth toe (TS), and the second toe to the fourth toe (IT) were measured on the
experimental side (E) and the contralateral normal side (N) in each rat. The sciatic
function index (SFI) of each animal was calculated by the following formula:
SFI ¼ 38:3 ðEPL  NPLÞ=NPL þ 109:5 ðETS NTSÞ=NTSþ 13:3
 ðEIT NITÞ=NIT 8:8
In general, SFI oscillates around 0 for normal nerve function, whereas
around 100 SFI represents total dysfunction. SFI was assessed in the NC group and
the normal level was considered as 0. SFI was a negative value and a higher SFI
meant the better function of the sciatic nerve.
2.5. Muscle mass
Recovery assessment was also indexed using the weight ratio of the gastro-
cnemius muscles 16 weeks after surgery. Immediately after sacriﬁcing of animals,
gastrocnemius muscles were dissected and harvested carefully from intact and
injured sides and weighed while still wet, using an electronic balance.
2.6. Histological preparation and morphometric studies
Nerve mid-substance in SIL group, nerve mid-substance in diclofenac treated
group, midpoint of normal sciatic nerve (Sham) and regenerated mid substance of
TC group were harvested and ﬁxed with glutaraldehyde 2.5%. They were post ﬁxed
in OsO4 (2%, 2 h), dehydrated through an ethanol series and embedded in Epon. The
nerves were cut in 5 mm in the middle, stained with toluidine blue and examineds of categories and attributes.20,21
nd slight movement of one other joint
no weight support
hen stationary) or occasional, frequent, or consistent weight supported dorsal
ation
rdination
-HL coordination
HL coordination
n; and predominant paw position during locomotion is rotated (internally or
t before it is lifted off at the end of stance or frequent plantar stepping consistent
oe clearance or occasional toe clearance during forward limb advancement;
ait; and toe clearance occurs frequently during forward limb advancement;
off
ait; and toe clearance occurs frequently during forward limb advancement;
ait; and toe clearance occurs consistently during forward limb advancement;
off
ait; and toe clearance occurs consistently during forward limb advancement;
ail is down part or all of the time
toe clearance; predominant paw position is parallel at initial contact and lift
toe clearance, predominant paw position is parallel throughout stance,
Fig. 2. Box-and-whisker plots of sciatic nerve function index values in each exper-
imental group during the study period. Topical administration of diclofenac with artery
grafting gave better results in functional recovery of the sciatic nerve than in AG group.
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analyzing software (Image-Pro Express, version 6.0.0.319, Media Cybernetics, Silver
Springs, MD, USA). Equal opportunity, systematic random sampling and two-
dimensional dissector rules were followed in order to cope with sampling-related,
ﬁber-location-related and ﬁber-size related biases.22
2.7. Immunohistochemical analysis
In this study, anti-S-100 (1:200, DAKO, USA) was used as marker for myelin
sheath. Specimens were post ﬁxed with 4% paraformaldehyde for 2 h and embedded
in parafﬁn. Prior to immunohistochemistry nerve sections were dewaxed and
rehydrated in PBS (pH 7.4). Then the nerve sections were incubated with 0.6%
hydrogen peroxide for 30 min. To block non-speciﬁc immunoreactions the sections
were incubated with normal swine serum (1:50, DAKO, USA). Sections were then
incubated in S-100 protein antibody solution for 1 h at room temperature. Theywere
washed three times with PBS and incubated in biotinylated anti-mouse rabbit IgG
solution for 1 h. Horseradish peroxidase-labelled secondary antibodywas applied for
1 h. After that all sections were incubated with 3,30- diaminobenzidine tetrahydro-
chloride chromogene substrate solution (DAB, DAKO, USA) for 10 min. The results of
immunohistochemistry were examined under a light microscope.
2.8. Statistical analysis
The results were expressed as means  SD. Statistical analyses were performed
using PASW 18.0 (SPSS Inc., Chicago, IL, USA). Model assumptions were evaluated by
examining the residual plot. Results were analyzed using a factorial ANOVAwith two
between-subjects factors. Bonferroni test for pairwise comparisons was used to
examine the effect of time and treatments. The differences were set at P < 0.05.
3. Results
3.1. BBB recovery
In order to assess hind limb recovery the open ﬁeld locomotor
was used. Fig. 1 shows BBB scores compared to the baseline. All
experimental groups, except for sham, showed the greatest degree
of functional deﬁcit one week after surgery. The diclofenac treated
group showed signiﬁcant improvement in locomotion of the
operated limb compared to the AG group during the study period
(P < 0.05).
3.2. Recovery of sciatic nerve function
Fig. 2 shows sciatic function index (SFI) values in all four
experimental groups. Prior to surgery, SFI values in all groups were
near zero. After the nerve transection, the mean SFI decreased
to 100 due to the complete loss of sciatic nerve function in all
animals. At the end of the study period, animals of diclofenac group
achieved a mean value for SFI of 60. 6  4.21 whereas in groupFig. 1. BBB score for all experimental groups. Topical administration of diclofenac with
artery grafting gave better scores than in AG group. Standard error at each data point is
shown with bars.AG a mean value of 44.1  3.19 was found. The statistical ana-
lyses revealed that the recovery of nerve function was signiﬁcantly
(P < 0.05) different between AG/DICLO and AG groups and appli-
cation of the diclofenac in artery graft signiﬁcantly accelerated
functional recovery in the course of time.
3.3. Muscle mass measurement
The mean ratios of gastrocnemius muscle weight were meas-
ured at the end of the study period. There was a statistically sig-
niﬁcant difference between the muscle weight ratios of the AG/
DICLO and AG groups (P < 0.05). The results showed that in the
diclofenac treated group, the muscleweight ratiowas larger than in
the AG group, and weight loss in the gastrocnemius muscle was
ameliorated by diclofenac topical administration (Fig. 3).
3.4. Histological and morphometric ﬁndings
The Table 1 shows the quantitative morphometric analyses of
regenerated nerves for each of the experimental groups. The
diclofenac treated group presented signiﬁcantly greater nerve ﬁber,
axon diameter, and myelin sheath thickness 4 weeks after surgery,Fig. 3. Gastrocnemius muscle weight measurement. The gastrocnemius muscles of
both sides (operated left and unoperated right) were excised and weighed in the
experimental groups at 16 weeks after surgery. Data are presented as mean  SD.
*P < 0.05 vs AG group.
Fig. 4. The graph shows the quantitative results of ﬁber counting. The mean number of
nerve ﬁbers in SHAM group was nearly 8326  211 (mean  SD). Both groups of AG
and AG/DICLO showed the lower number of ﬁbers than the sham-operated group even
at the end of the study period.
Fig. 6. The graph shows the quantitative results of mean diameter of axons. The mean
diameter of axons in SHAM group was nearly 7.3  0.09 (mean  SD). Both groups of
AG and AG/DICLO showed the lower mean diameter of axons than the sham-operated
group even at the end of the study period.
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sented signiﬁcantly greater nerve ﬁber and axon diameter, and
myelin sheath thickness compared to AG/DICLO and AG groups
animals (Figs. 4e7). In case of myelin thickness there was no sig-
niﬁcant difference between AG/DICLO and AG groups, morpho-
metrically (P > 0.05).
3.5. Immunohistochemistry
Immunoreactivity to S-100 protein was extensively observed in
the cross sections of regenerated nerve segments. The expression of
S-100 protein signal was located mainly in the myelin sheath. The
axon also showed a weak expression indicating that Schwann cell-
like phenotype existed around the myelinated axons (Fig. 8). In
both AG/DICLO and AG groups, the expression of S-100 and the
ﬁndings resembled those of the histological evaluations.
4. Discussion
The results of the present study showed that application of
diclofenac in an artery graft resulted in faster functional recovery ofFig. 5. The graph shows the quantitative results of mean diameter of nerves ﬁbers. The
mean diameter of nerve ﬁbers in SHAM group was nearly 12.6  0.11 (mean  SD).
Both groups of AG and AG/DICLO showed the lower mean diameter of nerve ﬁbers than
the sham-operated group even at the end of the study.the sciatic nerve during the study period. Left gastrocnemius
muscle weight was signiﬁcantly greater in the AG/DICLO group
than in the AG group, indicating indirect evidence of successful end
organ reinnervation in the diclofenac-treated animals. At week 16
quantitative morphometrical indices of regenerated nerve ﬁbers
showed signiﬁcant differences between the AG and AG/DICLO
groups, indicating a beneﬁcial effect of topical application of
diclofenac on the nerve regeneration.
Castaneda et al.,23 suggested that arrival of sprouts from the
proximal stump at the distal nerve stump does not necessarily
imply recovery of nerve function. Information taken from BBB scale
may be invaluable in evaluation of peripheral nerve process. Results
of the present study showed that the diclofenac treated animals
had been improved in locomotion of the operated limb compared
to the AG group during the study period. Walking track analysis has
frequently been used to reliably determine functional recovery
following nerve repair in rat models.21,24
A wide variety of materials have been used to produce nerve
guides, including non-biodegradable and biodegradable materials.
Because of its inert and elastic properties, the silicon tube was one
of the ﬁrst and most frequently used to bridge the transectedFig. 7. The graph shows the quantitative results of mean thickness of myelin sheath.
The mean thickness of myelin sheath in SHAM group was nearly 2.4  0.04
(mean  SD). Both groups of AG and AG/DICLO showed the lower mean diameter of
axons than the sham-operated group even at the end of the study period.
Fig. 8. Immunohistochemical analysis of the regenerated nerves 16 weeks after surgery from (A) middle cable TC, (B) SHAM, (C) AG and (D) AG/DICLO. There is clearly more positive
staining of the myelin sheath-associated protein S-100 (arrows) within the periphery of nerve, indicating well organized structural nerve reconstruction in diclofenac treated nerve
compared to that of the SIL. Scale bar:10 mm.
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ﬁbrous capsule formation, leading to chronic nerve compression
and an inﬂammatory response.26 In order to avoid problems
associated with non-degradable guides, recent research has been
focused on the production of biodegradable nerve guides.27
Copolymer of 50% DL-lactide and 50% _ caprolactone (Polyganics
B.V.) is a biodegradable guide that is effective in supporting the
outgrowth of axons and allows faster axonal regeneration and
better recovery.28 In addition, these guides provide a good tool to
administrate factors which can improve the regeneration of injured
peripheral nerves in human. However, such a biodegradable guides
collapse easily because of their thinwalls.29 Veins and arteries have
been experimentally used as grafting tubules.30 In contrast to vein
wall arterywalls are quite rigid and in some animals the graft might
cause excessive pressure on the nerve diameter and hypoxia, thus
impairing regeneration.31
Ectopic neural discharge originating from experimentally
induced neuromas is inhibited by locally applied corticosteroids,
whether they are administered at the time of nerve injury or after
abnormal neural activity has become established.32 Hong et al.,33
demonstrated in animals with experimentally induced com-
pression neuropathy that local steroid injection at the site of nerve
compression may facilitate the recovery of nerve conduction block
but not the recovery of a demyelinating lesion.
Impairment in the blood ﬂow can leads to microvascular per-
meability alterations and subsequent extravasation of blood from
the vessels and edema formation.34 The extravasation of blood and
the leakage of inﬂammatory mediators then may result in sec-
ondary changes such as inﬂammatory reactions and the develop-
ment of intraneural ﬁbrosis. Injections of corticosteroids, as well as
oral, intramuscular, or intravenous administration of nonsteroidal
anti-inﬂammatory drugs (NSAIDs) have been used clinically for
many years as part of the conservative treatment for patients with
painful disc herniation and sciatica.35
Beneﬁcial effect of topical application of betamethasone has
recently been documented in our work.36 However, the patho-
physiologic mechanisms of anti-inﬂammatory agents on the nerve
are largely unknown. It has been demonstrated the acetyl salicylic
acid and celecoxib, NSAIDs, could accelerate functional recovery of
nerve regeneration in experimentally induced crush lesions.37,38
Regarding topical effect of non-steroidal anti-inﬂammatory drugs
on nerve regeneration, to the author’s knowledge, no earlier
experimental studies have evaluated the local effects of diclofenac
on transected sciatic nerve. Acetyl salicylic acid (ASA) is one of the
most widely used analgesic, anti-pyretic and anti-inﬂammatory
drug. ASA exerts these effects through inhibition of cyclo-
oxygenases (COX).39 However novel COX-independent actions of
ASA like, inhibition of excitatory amino acid release, NF-kappa beta
(Nfkb) translocation to the nucleus and expression of induciblenitric acid synthase (iNOS) following cerebral ischemia are projec-
ting ASA as a promising neuroprotective agent for treating stroke.40
Neuroprotective effects of diclofenac has been studied elsewhere,
however, the mechanism of action has not been investigated.35
Diclofenac is one of the most widely prescribed NSAIDs for its
analgesic, and anti-inﬂammatory indications. It is also available as
an over the counter product in some countries. Similar to other
NSAIDs, diclofenac use is associated with rare, but serious and
sometimes fatal, gastrointestinal (GI) side effects, including ulcer-
ation, and hemorrhage, especially in the elderly.41,42
To overcome the drawback it has been reported to minimize the
dosage or to limit the duration of therapy.43 The results of the
present study indicated that a single topical administration of
diclofenac at the site of transected nerve could be of beneﬁt after
nerve tubulization without adverse effects of chronic systemic
administration.
Even though our preliminary study shows the neuroprotective
action of local diclofenac in peripheral nerve injuries, data
regarding the molecular mechanisms leading to the neuro-
protective action is still lacking. We have not given the histological
and molecular evidence for neuroprotective action of diclofenac.
This may be considered as a limitation to our study.
Therefore, the authors stress that the aim of the current inves-
tigation was to evaluate a single local dose and clinical treatment
potential of diclofenac on nerve regeneration. The results of the
present study indicated that a single topical administration of
dexamethasone at the site of transected nerve could be of beneﬁt
after artery graft tubulization. Mechanism of neuroprotective ac-
tion remains to be investigated.
5. Conclusion
The present study demonstrated that local application of
diclofenac could accelerate functional recovery after transection of
sciatic nerve. It is available and easily performed without limita-
tions and complications of adverse effects compared to its chronic
systemic administration. Thus, doseeresponse studies should be
conducted for diclofenac to determine the combination of the graft
and the compound that achieve maximal efﬁcacy in nerve trans-
ection models.
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